Medacta International SA
51
16
31
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
5.9%
3 terminated/withdrawn out of 51 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
25%
3 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (51)
Mechanical Alignment vs Kalipered Kinematic Alignment Total Knee Arthroplasty
Role: collaborator
Medacta NextAR TKA Pivotal Trial
Role: lead
Stability of Uncemented Medially Stabilized TKA
Role: collaborator
Stability of Contemporary Knee Arthroplasty
Role: collaborator
Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral Component
Role: lead
Monocer AOANJRR Registry-nested Study
Role: lead
The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study
Role: lead
Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay
Role: lead
EBRA Study AMISTEM-C FR
Role: lead
The Medacta GMK SpheriKA Post-Marketing Surveillance Study
Role: lead
Bone Fixation of Mpact Double Mobility Cup
Role: lead
The Medacta Quadra-P Anteverted Study
Role: lead
The Medacta International SMS Post-Marketing Surveillance Study
Role: lead
Multicenter Mpact DM France
Role: lead
AMIStem-H Radiological Assessment
Role: lead
Clinical and Radiological Outcomes of Medacta Shoulder System
Role: lead
RSA Masterloc Study Australia
Role: lead
A Post-Market, Retrospective Study on 3D Metal Tibial and Femoral Cones
Role: lead
Clinical Utility and Gait Analysis of NextAR System AUS
Role: lead
Clinical and Radiological Outcomes of Medacta Shoulder System (BE)
Role: lead